About Us

Wedbush Bullish On Sarepta's Eteplirsen Data

By: via Benzinga
Wedbush’s Heather Behanna believes there is a “good chance” that eteplirsen would receive approval in 3Q16, if ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.